Realbotix Reports Financial Results for Q2-2026
Go back to Realbotix Reports Financial Results for Q2-2026| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 1.02 -0.07 (6.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $0.00 | |||
| Open | $1.08 | 52 Week Low | $0.00 | |||
| Day High | $1.11 | P/E | N/A | |||
| Day Low | $0.95 | EPS | $0.00 | |||
| Volume | 399,575 | |||||
| (AMEX: XBOTF) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $ | |||
| Open | $0.20 | 52 Week Low | $ | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.20 | EPS | $ | |||
| Volume | 253,559 | |||||
